FRANKLIN LAKES, N.J., April 13, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD MAX™ Molecular Multi-Drug ...
CAPE TOWN, South Africa, Nov. 5 BD (Becton,Dickinson and Company) (NYSE: BDX), a leading global medical technologycompany, and FIND (Foundation for Innovative New Diagnostics), a non-profitproduct ...
Join us for an insightful webinar to discuss a holistic approach to testing for TB in a clinical setting. Tuberculosis remains a global health challenge, with significant hurdles in diagnosing and ...
With multi-drug resistant tuberculosis emerging as a major obstacle in the fight against tuberculosis, doctors advocated the need for a collective move to adopt appropriate diagnostic mechanisms that ...
A test has become available in Europe which can simultaneously detect bacteria that cause tuberculosis (TB) and determine if the bacteria contain mutations associated with resistance to two important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results